Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

The C-terminal tail of AHF/trichohyalin is essential for organizing keratin filaments in keratinocytes.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Matriptase is crucial for skin, hair, and immune cell health, and its imbalance can lead to cancer.

Trichosanthes kirilowii extract helps wounds heal faster.

Nilotinib can cause keratosis pilaris, a skin condition.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

FAKΔe4 helps cells sense and respond to different stiffness levels in their environment.

Sgk3 is essential for normal hair follicle growth and maintenance.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Ruxolitinib helped a patient with alopecia areata regrow hair.

ACA2 is crucial for root hair growth by controlling calcium levels in cells.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

RORA boosts autophagy in hair follicle stem cells, potentially aiding hair growth.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

Specific mutations in a receptor cause facial abnormalities and hair loss.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Signals from skin cells controlled by Rac proteins help turn certain precursor cells into white fat cells.